NYLI Income Builder Class C MCTRX

Medalist Rating as of | See New York Life Investment Hub
  • NAV / 1-Day Return 26.61  /  −0.11 %
  • Total Assets 1.2B
  • Adj. Expense Ratio
    2.030%
  • Expense Ratio 2.030%
  • Distribution Fee Level High
  • Share Class Type Level Load
  • Category Global Moderate Allocation
  • Investment Style Large Value
  • Credit Quality / Interest Rate Sensitivity
  • Status Open
  • TTM Yield 1.45%
  • Turnover 50%

USD | NAV as of Aug 15, 2026 | 1-Day Return as of Aug 15, 2026, 12:11 AM GMT+0

Morningstar’s Analysis MCTRX

Will MCTRX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

This fund’s ratings are under review.

Analyst Stephen Margaria

Stephen Margaria

Analyst

Summary

NYLI Income Builder is Under Review following a management change. On Aug. 10, 2026, New York Life Investment Management announced that portfolio manager Amit Soni will step down from the fund at the end of August 2026 to pursue an opportunity outside the firm. NYLIM had named Soni as a comanager just one month earlier, in anticipation of key leader Jonathan Swaney's April 2027 retirement. Soni had comanaged other NYLIM asset-allocation strategies with Swaney since 2016, and his addition here represented a clear succession plan. However, his exit so soon after being named leaves that plan in question.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings MCTRX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 14.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Yen

3.90 46M
Cash and Equivalents

United States Treasury Notes 4.125%

2.70 32M
Government

NYLI U.S. Government Liquidity Class I

2.21 26M
Cash and Equivalents

United States Treasury Bonds 5%

1.66 20M
Government

Taiwan Semiconductor Manufacturing Co Ltd ADR

1.54 18M
Technology

Dell Technologies Inc Ordinary Shares - Class C

1.43 17M
Technology

Cisco Systems Inc

1.38 16M
Technology

Australian Dollar

1.37 16M
Cash and Equivalents

CVS Health Corp

1.28 15M
Healthcare

Texas Instruments Inc

1.23 14M
Technology

Sponsor Center